NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
Rhea-AI Summary
NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company specializing in neurological disorder surgical care, has announced its upcoming fiscal first quarter 2025 financial results release scheduled for February 12, 2025, before market open.
The company will host an investor conference call and webcast at 8:30 a.m. Eastern time on the same day, featuring management's discussion of Q1 2025 results, a corporate update, and a Q&A session. The earnings call will be accessible via U.S. toll-free (888-506-0062) and international (973-528-0011) dial-in numbers, with participant access code 234314.
A playback will be available until February 26, 2025, through domestic and international replay numbers, using passcode 51728. The webcast replay will be accessible through February 13, 2025.
Positive
- None.
Negative
- None.
News Market Reaction – NMTC
In the trading session that priced this news, NMTC gained 0.95%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal first quarter ended December 31, 2024, before market open on February 12, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. eastern time on Wednesday, February 12, 2025, to discuss the Company’s first quarter 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
First Quarter and Fiscal 2025 Earnings Conference Call
Date: Wednesday, February 12, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 234314
Webcast: https://www.webcaster4.com/Webcast/Page/2821/52002
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Wednesday, February 26, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 51728. A webcast replay will also be available using the webcast link above through February 13, 2025.
About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us
